BUPRENORPHINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Market Segmentation

• Brand Insights (Revenue, USD Mn, 2023 - 2035)

  • Sublocade (buprenorphine extended‐release)
  • Suboxone (buprenorphine and naloxone)
  • Brixadi (buprenorphine extended‐release)
  • Zubsolv (buprenorphine and naloxone)
  • Others (Belbuca, Butrans and among others)

• Type Insights (Revenue, USD Mn, 2023 - 2035)

  • Branded
  • Generics

• Route of Administration Insights (Revenue, USD Mn, 2023 - 2035)

  • Injectable
    • Intravenous
    • Intramuscular
    • Subcutaneous
  • Sublingual
  • Buccal
  • Transdermal
  • Others

• Dosage Form Insights (Revenue, USD Mn, 2023 - 2035)

  • Injectable Solutions
  • Patches
  • Films
  • Others (Tablets, etc.)

• Indication Insights (Revenue, USD Mn, 2023 - 2035)

  • Opioid Use Disorder (OUD)
  • Pain Management
  • Acute Pain
  • Chronic Pain

• Formulation Type Insights (Revenue, USD Mn, 2023 - 2035)

  • Single Drug Formulation
  • Fixed Dose Combination

• Age Group Insights (Revenue, USD Mn, 2023 - 2035)

  • Adults
  • Pediatric

• Distribution Channel Insights (Revenue, USD Mn, 2023 - 2035)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

• Regional Insights (Revenue, USD Mn, 2023 - 2035)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa